(Reuters) -BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United ...

Spanish bread and pastry maker Europastry SA is planning to kick off its initial public offering in Spain, according to ...

National Stock Exchange of India Ltd.’s valuation in the private markets has doubled to $36 billion in the last four months, ...

Ibotta CEO Bryan Leach thinks it's a "huge mistake" to try to time the IPO market because the IPO process is long.

Upstream Bio plans to IPO to advance its Phase 2 drug candidate, verekitug, for severe asthma and chronic rhinosinusitis.

A decision on an IPO is for the shareholder ADQ to make, the CEO of Abu Dhabi's Etihad Airways, Antonoaldo Neves, said on ...

BioAge Labs is eyeing around $180 million in initial proceeds from an IPO and a private placement, funds the ...

The 12 initial public offerings so far in 2024 on the Australian stock exchange have raised just $371mn, according to data ...

Nithin Kamath, CEO of Zerodha, explained why the trading platform hasn't gone public, focusing on risk diversification and ...

Glottis, a Chennai-based logistics service provider, plans to raise Rs 450-500 crore through an IPO. The offering includes a ...

Manba Finance’s Initial Public Offering (IPO) saw an unprecedented 223.12 times subscription on its closing day, Wednesday.

Estimates from British think tank Tax Policy Associates suggest that Shein has dodged taxes worth £150 million ($201 million) ...